Publications by authors named "Lucia Vincenzetti"

Currently circulating SARS-CoV-2 variants have acquired convergent mutations at hot spots in the receptor-binding domain (RBD) of the spike protein. The effects of these mutations on viral infection and transmission and the efficacy of vaccines and therapies remains poorly understood. Here we demonstrate that recently emerged BQ.

View Article and Find Full Text PDF
Article Synopsis
  • Chronic hepatitis B is a major global health issue, and co-infection with hepatitis delta virus (HDV) can worsen the disease; researchers are studying a monoclonal antibody (mAb) targeting hepatitis B virus (HBV) surface antigen (HBsAg) for potential treatment.
  • The monoclonal antibodies were developed from memory B cells of vaccinated individuals and tested in human liver-chimeric mice to observe their effectiveness against HBV and HDV in various stages of infection.
  • The chosen mAb, VIR-3434, showed strong neutralization capabilities against multiple HBV genotypes, significantly reducing virus levels in treated mice and is now being considered for clinical trials in humans with chronic hepatitis B or D.
View Article and Find Full Text PDF

Currently circulating SARS-CoV-2 variants acquired convergent mutations at receptor-binding domain (RBD) hot spots. Their impact on viral infection, transmission, and efficacy of vaccines and therapeutics remains poorly understood. Here, we demonstrate that recently emerged BQ.

View Article and Find Full Text PDF

The appropriate regulation of T lymphocyte functions is key to achieve protective immune responses, while at the same time limiting the risks of tissue damage and chronic inflammation. Deciphering the mechanisms underpinning T cell responses in humans may therefore be beneficial for a range of infectious and chronic diseases. Recently, the development of methods based on CRISPR-Cas9 gene-editing has greatly expanded the available tool-box for the mechanistic studies of primary human T cell responses.

View Article and Find Full Text PDF

In mammals, the 5'-methylcytosine (5mC) modification in the genomic DNA contributes to the dynamic control of gene expression. 5mC erasure is required for the activation of developmental programs and occurs either by passive dilution through DNA replication, or by enzymatic oxidation of the methyl mark to 5-hydroxymethylcytosine (5hmC), which can persist as such or undergo further oxidation and enzymatic removal. The relative contribution of each mechanism to epigenetic control in dynamic biological systems still remains a compelling question.

View Article and Find Full Text PDF

The risk of developing autoimmune diseases depends on both genetic and environmental factors, with epigenetic mechanisms of regulation potentially translating environmental cues into stable modifications in gene expression. Such stable memory of a functional state has been deciphered into a number of molecular mechanisms that collectively define the epigenetic status of a cell. In recent years, it has become increasingly clear that epigenetic modifications are highly dynamic and are able to adapt to the changing environment, with important impact on the onset and development of a number of diseases.

View Article and Find Full Text PDF